Unisel Overseas (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.90 M
- Company Age 27 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -23.20%
- Profit Growth 51.15%
- Ebitda 57.01%
- Net Worth 1.72%
- Total Assets 7.80%
About Unisel Overseas (India)
Unisel Overseas (India) Private Limited (UOIPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 July 1997 and has a history of 27 years and six months. Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.90 M, as per Ministry of Corporate Affairs (MCA) records.
Ratnawali Singh and Prateek Singh serve as directors at the Company.
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U15127UP1997PTC022339
- Company No.
022339
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jul 1997
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Unisel Overseas (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ratnawali Singh  | Director | 23-Jul-1997 | Current |
| Prateek Singh | Director | 23-Jul-1997 | Current |
Financial Performance of Unisel Overseas (India).
Unisel Overseas (India) Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 23.2% decrease. The company also saw a substantial improvement in profitability, with a 51.15% increase in profit. The company's net worth moved up by a moderate rise of 1.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unisel Overseas (India)?
In 2023, Unisel Overseas (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ps Global Consumer Healthcare Private LimitedRatnawali Singh and Prateek Singh are mutual person
Sanjivan Healthcare Enterprise Private LimitedRatnawali Singh and Prateek Singh are mutual person
- Unisel Infraservices And Trade Private Limited
Ratnawali Singh and Prateek Singh are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Unisel Overseas (India)?
Unlock and access historical data on people associated with Unisel Overseas (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unisel Overseas (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unisel Overseas (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
